Farnier M - Search Results

1

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study.

Stroes E, Guyton JR, Lepor N, Civeira F, Gaudet D, Watts GF, Baccara-Dinet MT, Lecorps G, Manvelian G, Farnier M; ODYSSEY CHOICE II Investigators. Stroes E, et al. Among authors: farnier m. J Am Heart Assoc. 2016 Sep 13;5(9):e003421. doi: 10.1161/JAHA.116.003421. J Am Heart Assoc. 2016. PMID: 27625344 Free PMC article. Clinical Trial.

2

Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.

Farnier M, Bonnefous F, Debbas N, Irvine A. Farnier M, et al. Arch Intern Med. 1994 Feb 28;154(4):441-9. Arch Intern Med. 1994. PMID: 8117177 Clinical Trial.

3

Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia.

Farnier M, Portal JJ, Maigret P. Farnier M, et al. J Cardiovasc Pharmacol Ther. 2000 Jan;5(1):27-32. doi: 10.1177/107424840000500104. J Cardiovasc Pharmacol Ther. 2000. PMID: 10687671 Clinical Trial.

4

Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.

Farnier M, Dejager S. Farnier M, et al. Am J Cardiol. 2000 Jan 1;85(1):53-7. doi: 10.1016/s0002-9149(99)00606-2. Am J Cardiol. 2000. PMID: 11078237 Clinical Trial.

5

Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia.

Farnier M, Freeman MW, Macdonell G, Perevozskaya I, Davies MJ, Mitchel YB, Gumbiner B; Ezetimibe Study Group. Farnier M, et al. Eur Heart J. 2005 May;26(9):897-905. doi: 10.1093/eurheartj/ehi231. Epub 2005 Mar 21. Eur Heart J. 2005. PMID: 15781429 Clinical Trial.

6

New strategies in the treatment of hypercholesterolemia.

Kastelein J, Farnier M. Kastelein J, et al. Among authors: farnier m. Timely Top Med Cardiovasc Dis. 2005 Oct 17;9:E32. Timely Top Med Cardiovasc Dis. 2005. PMID: 16341285 No abstract available.

7

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.

Farnier M, Roth E, Gil-Extremera B, Mendez GF, Macdonell G, Hamlin C, Perevozskaya I, Davies MJ, Kush D, Mitchel YB; Ezetimibe/Simvastatin + Fenofibrate Study Group. Farnier M, et al. Am Heart J. 2007 Feb;153(2):335.e1-8. doi: 10.1016/j.ahj.2006.10.031. Am Heart J. 2007. PMID: 17239698 Clinical Trial.

8

Efficacy and safety of adding fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by pravastatin 40 mg monotherapy.

Farnier M, Ducobu J, Bryniarski L. Farnier M, et al. Am J Cardiol. 2010 Sep 15;106(6):787-92. doi: 10.1016/j.amjcard.2010.05.005. Epub 2010 Aug 2. Am J Cardiol. 2010. PMID: 20816118 Clinical Trial.

9

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials.

Leiter LA, Betteridge DJ, Farnier M, Guyton JR, Lin J, Shah A, Johnson-Levonas AO, Brudi P. Leiter LA, et al. Among authors: farnier m. Diabetes Obes Metab. 2011 Jul;13(7):615-28. doi: 10.1111/j.1463-1326.2011.01383.x. Diabetes Obes Metab. 2011. PMID: 21332628

10

Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.

Guyton JR, Betteridge DJ, Farnier M, Leiter LA, Lin J, Shah A, Johnson-Levonas AO, Brudi P. Guyton JR, et al. Among authors: farnier m. Diab Vasc Dis Res. 2011 Apr;8(2):160-72. doi: 10.1177/1479164111406457. Diab Vasc Dis Res. 2011. PMID: 21562068 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page